Trial · NCT02717455
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 40 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Half-life (t1/2) | Stratum 1, Dose Level 1 (10 mg/m^2) | 13.0 | Standard Deviation 4.0 | hour | |
| Half-life (t1/2) | Stratum 1, Dose Level 2 (16 mg/m^2) | 11.0 | Standard Deviation 2.0 | hour | |
| Half-life (t1/2) | Stratum 2, Dose Level 1 (16 mg/m^2) | 14.7 | Standard Deviation 1.1 | hour | |
| Half-life (t1/2) | Stratum 2, Dose Level 2 (22 mg/m^2) | 12.6 | Standard Deviation 2.8 | hour | |
| Half-life (t1/2) | Stratum 2, Dose Level 3 (28 mg/m^2) | 14.8 | Standard Deviation 1.9 | hour | |
| Half-life (t1/2) | Stratum 2, Dose Level 4 (36 mg/m^2) | 11.3 | Standard Deviation 3.8 | hour | |
| Clearance (CL/F) | Stratum 1, Dose Level 1 (10 mg/m^2) | 87 | Standard Deviation 19 | L/h | |
| Clearance (CL/F) | Stratum 1, Dose Level 2 (16 mg/m^2) | 146 | Standard Deviation 104 | L/h | |
| Clearance (CL/F) | Stratum 2, Dose Level 1 (16 mg/m^2) | 156 | Standard Deviation 44 | L/h | |
| Clearance (CL/F) | Stratum 2, Dose Level 2 (22 mg/m^2) | 115 | Standard Deviation 34 | L/h | |
| Clearance (CL/F) | Stratum 2, Dose Level 3 (28 mg/m^2) | 93 | Standard Deviation 26 | L/h | |
| Clearance (CL/F) | Stratum 2, Dose Level 4 (36 mg/m^2) | 129 | Standard Deviation 109 | L/h | |
| Area Under the Curve (AUC) | Stratum 1, Dose Level 1 (10 mg/m^2) | 102 | Standard Deviation 44 | h*ng/mL | |
| Area Under the Curve (AUC) | Stratum 1, Dose Level 2 (16 mg/m^2) | 191 | Standard Deviation 146 | h*ng/mL | |
| Area Under the Curve (AUC) | Stratum 2, Dose Level 1 (16 mg/m^2) | 143 | Standard Deviation 64 | h*ng/mL | |
| Area Under the Curve (AUC) | Stratum 2, Dose Level 2 (22 mg/m^2) | 239 | Standard Deviation 71 | h*ng/mL | |
| Area Under the Curve (AUC) | Stratum 2, Dose Level 3 (28 mg/m^2) | 284 | Standard Deviation 73 | h*ng/mL | |
| Area Under the Curve (AUC) | Stratum 2, Dose Level 4 (36 mg/m^2) | 372 | Standard Deviation 222 | h*ng/mL | |
| Progression-free Survival (PFS) in Stratum 1 | Stratum 1 | 1.87 | Full Range 0.73 to 9.00 | months | |
| Overall Survival (OS) in Stratum 1 | Stratum 1 | 5.23 | Full Range 0.73 to 36.60 | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02717455/results?page=2